New Once-Daily drug could simplify Wilson's disease treatment
Disease control
Not yet recruiting
This Phase 3 trial compares a new once-daily formulation of trientine tetrahydrochloride (TETA 4HCl) to the standard drug D-penicillamine for people newly diagnosed with Wilson's disease. About 38 adults and children (ages 8 and up, weighing at least 55 lbs) will be randomly assi…
Phase: PHASE3 • Sponsor: Orphalan • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC